- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
About this Journal
An exciting journal in the area of contrast agents and molecular imaging, covering all areas of imaging technologies with a special emphasis on MRI.
Contrast Media & Molecular Imaging (CMMI) provides an international forum for the expeditious publication of research articles, reviews, clinical studies, and letters to the editors in the booming areas of contrast media & molecular imaging. CMMI is aimed at the academic, medical, and industrial communities, at the developers and users of these emerging and rapidly developing technologies, mainly in the areas of Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy, but also embracing all other in vivo imaging technologies such as x-Ray, PET/CT, etc.
Molecular imaging articles will concentrate on the potential role played by MR Imaging and MR Spectroscopy at visualizing, at the molecular or cellular level, the physiology and physio-pathological processes in humans and in animals.
Contrast Media articles will cover innovative work on all aspects of this field, such as the development of more sensitive agents, comparison of MR Imaging with other imaging modalities, and prompting of multi-modality approaches.
Contrast Media & Molecular Imaging will devote particular attention to the following fields: synthesis, characterization, and applications of new magnetic reporters, search for new vectors, coupling strategies, in vitro as well in vivo evaluation of new methodologies and applications.
The most recent Impact Factor for Contrast Media & Molecular Imaging is 3.286 according to the 2015 Journal Citation Reports released by Thomson Reuters in 2016.
Content published prior to 2017 is hosted on the Wiley Online Library.
Contrast Media & Molecular Imaging currently has an acceptance rate of 29%. The average time between submission and final decision is 38 days and the average time between acceptance and publication is 27 days.
The Wiley Hindawi Partnership
This journal is published by Hindawi as part of a publishing collaboration with John Wiley & Sons, Inc. It is a fully Open Access journal produced under the Hindawi and Wiley brands. For more information please click here.